Xeris Pharmaceuticals | Les Charges D'Exploitation

Prix De L'Action
6.64
Variation Quotidienne
0.06 0.84%
Mensuellement
-11.30%
Annuel
81.28%
Q1 Prévisions
6.41




Les Charges D'Exploitation Changement Date
Celltrion KRW 724.99B 6B 2025-09
Cspc Pharmaceutical CNY 5.4B 298.41M 2025-09
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 40.68M 5.56M 2025-09
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 10.02M 9.78M 2025-06
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neuren Pharmaceuticals AUD 8.69M 8.72M 2025-06
Organigram Holdings CAD 108.11M 17.03M 2025-09
Ovoca Bio EUR 5.65M 3.45M 2022-06
Pacira USD 166.36M 4.5M 2025-09
Perrigo USD 949.9M 50.8M 2025-09
Pharma Mar EUR 39.62M 7.34M 2025-09
Qiagen NV USD 418.54M 23.25M 2025-12
Sartorius EUR 693.1M 29.4M 2025-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Supernus Pharmaceuticals USD 252.29M 98.98M 2025-09
Tilray USD 237.52M 17.34M 2025-09
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09


Xeris Pharmaceuticals Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.